MS Views and News Be empowered with MS views and news. To receive The MS BEACON e-Newsletter, CLICK HERE - -

Visit our MS learning channel on YouTube, which provides hundreds of MS educational videos presented by MS Experts from across the USA. Archived here: www.youtube.com/msviewsandnews -- Also please visit our Social media platforms: Facebook, Twitter, and Instagram . Each providing important information for the MS community. Furthermore, scroll down the left side of this blog to learn from the resources and links.

Disclaimer: 'MS Views and News' DOES NOT endorse any products or services found on this blog. It is up to you to seek advice from your healthcare provider. The intent of this blog is to provide information on various medical conditions, medications, treatments, for your personal knowledge and to keep you informed of current health-related issues. It is not a substitute for the advice of your physician. Should you or your family members have any specific medical problem, seek medical care promptly.

~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~


Tuesday, August 28, 2012

Fast Forward and the University of Cambridge collaborate to find new drugs that will repair the nervous system in people with MS



Aug 20, 2012
Research - Restore button
Fast Forward, LLC, a not-for-profit subsidiary of the National MS Society, is funding research at the Universities of Cambridge and Edinburgh, UK to screen for compounds that can stimulate myelin repair in MS. Myelin is the substance that surrounds nerve fibers and is a target of the immune attack on the brain and spinal cord in MS.
The project, which will be directed by Robin Franklin, PhD, DVM, grew out of findings from a Nervous System Repair and Protection Initiative funded through the Society’s Promise:2010 campaign. Drs. Franklin and Charles ffrench-Constant, PhD (University of Edinburgh) found a molecule called RXR-gamma that is “turned on” following myelin damage, and which play a role in forming new myelin. Now Dr. Franklin is being funded to find molecules that can stimulate RXR-gamma. The award provides Dr. Franklin with $200,000 over a 12-month period that started July 13, and like other Fast Forward partnerships, payments will be contingent upon the completion of specific milestones.
Dr. Franklin and colleagues are working with Domainex, a drug discovery company that has an exceptional track record of drug candidate delivery. Dr. Franklin’s team and Domainex are using a proven virtual screening method that will allow them to identify a library of about 1,000 molecules that can promote RXR activity.
“We are thrilled to collaborate with the world class team of scientists led by Dr. Franklin,” said Dr. Timothy Coetzee, Chief Research Officer at the National MS Society. “Driving research to restore function in people with MS is a critical component of the Society’s research strategy.”
Read more about Fast Forward.
Read more about efforts to restore function to people with MS. 


..


We appreciate commenting on our stories.
 Please note that all comments are moderated. 

LIKE this Blog by clicking the LIKE button - top left

 REMAIN up to date with MS News, Information and Education
Visit: www.msviewsandnews.org  to sign-up

~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~

No comments: